ArticleThe Journal of urology2019

Re: CRISPR/Cas9-Mediated Glycolate Oxidase Disruption is an Efficacious and Safe Treatment for Primary Hyperoxaluria Type I.

Dean G AssimosPubMed ↗Publisher ↗

No numbers read from the abstract.